Table 1 Distribution of BGCs and functional genes in probiotic Bacillus
From: Mechanisms of probiotic Bacillus against enteric bacterial infections
Type of BGCsa | B. cereus group | B. subtilis group | Bacillus spp. |
|---|---|---|---|
NRPS | 100% (84/84) | 99% (300/302) | 50% (33/66) |
NRPS-PKS | 26% (22/84) | 81% (244/302) | 15% (10/66) |
Bacteriocin | 100% (84/84) | 70% (210/302) | 62% (41/66) |
Lanthipeptide | 44% (37/84) | 55% (167/302) | 20% (13/66) |
Lassopeptide | 17% (14/84) | 12% (37/302) | 18% (12/66) |
Thiopeptide | 1% (1/84) | 21% (63/302) | 2% (1/66) |
Sactipeptide | 17% (14/84) | 31% (95/302) | 6% (4/66) |
PKS | - | 97% (293/302) | 77% (51/66) |
Phosphonate | - | 9% (26/302) | 11% (7/66) |
QSM | 100% (84/84) | 34% (104/302) | 2% (1/66) |
Immunomodulatory molecule | 46% (39/84) | 99% (300/302) | 61% (40/66) |
Siderophore | 82% (69/84) | 13% (40/302) | 30% (20/66) |
Terpene | 100% (84/84) | 98% (297/302) | 76% (50/66) |
Vitamin | 100% (84/84) | 88% (266/302) | 38% (25/66) |
other | 73% (61/84) | 96% (290/302) | 41% (27/66) |